ATC J07BX — Spain

Abrysvo powder and solvent for solution for injection

Form: powder and solvent for solution for injection

Active substance	Dosage
RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP A, F PROTEIN SUBUNIT 847A STABILIZED IN PREFUSION	0,06 mg
RESPIRATORY SYNCYTIAL VIRUS, SUBGROUP B, F PROTEIN SUBUNIT 847B STABILIZED IN PREFUSION	0,06 mg

ATC code: J07B, J07BX, J07BX05

Form: powder and suspension for injectable suspension

Active substance	Dosage
VACCINE (RSVPREF) OF STABILIZED F SUBUNIT IN PREFUSION AGAINST RESPIRATORY SYNCYTIAL VIRUS	120 µg

ATC code: J07B, J07BX, J07BX05

Form: solution for injection

Active substance	Dosage
mRNA vaccine encoding the viral spike S protein of SARS-CoV-2 Omicron LP.8.1	10 µg

ATC code: J07B, J07BX

Form: solution for injection, concentrate

Active substance	Dosage
mRNA vaccine encoding the viral spike S protein of SARS-CoV-2 Omicron LP.8.1	3 µg

ATC code: J07B, J07BX

Form: solution for injection

Active substance	Dosage
mRNA vaccine encoding the viral spike S protein of SARS-CoV-2 Omicron LP.8.1	30 µg

ATC code: J07B, J07BX

Form: powder and solvent for solution for injection

Active substance	Dosage
DENGUE VIRUS LIVE ATTENUATED SEROTYPE 1	≥ 3,3 log10 Unidades formadoras de placa/dosis (UFP/DOSIS)
DENGUE VIRUS LIVE ATTENUATED SEROTYPE 2	≥ 2,7 log10 Unidades formadoras de placa/dosis (UFP/DOSIS)
DENGUE VIRUS LIVE ATTENUATED SEROTYPE 3	≥ 4 log10 Unidades formadoras de placa/dosis (UFP/DOSIS)
DENGUE VIRUS LIVE ATTENUATED SEROTYPE 4	≥ 4,5 log10 Unidades formadoras de placa/dosis (UFP/DOSIS)

ATC code: J07B, J07BX, J07BX04

Manufacturer: Takeda Gmbh